✦ LIBER ✦

Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial

✍ Scribed by Michel Delforge; Ravinder Dhawan; Don Robinson Jr; Juliette Meunier; Antoine Regnault; Dixie-Lee Esseltine; Andrew Cakana; Helgi van de Velde; Paul G. Richardson; Jesús F. San Miguel

Book ID: 114795707
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 288 KB
Volume: 89
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2012.01788.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN140 IMPACT OF TUMOR RESPONSE ON HEALT

PCN140 IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP): RESULTS FROM THE VISTA TRIAL

✍ J Meunier; A Regnault; D Robinson; K Rosa; JF San Miguel; H van de Velde; PG Ric 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Effect of thalidomide with melphalan and

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

✍ Silvia G. R. Verelst; F. Termorshuizen; C. A. Uyl-de Groot; M. R. Schaafsma; A. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 274 KB

Bortezomib is associated with better hea

Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study

✍ Stephanie J. Lee; Paul G. Richardson; Pieter Sonneveld; Michael W. Schuster; Dav 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB